Mellon became a billionaire from different routes outside of health and longevity but has since become extremely bullish on the space. He’s published a book, started a biopharma company, and is investing over $65 million across 9 promising biotech companies to capitalize on the opportunity.

Read full interview here

Leave a Reply

%d bloggers like this: